A.L. Messchendorp

No picture available
E-mail:
a.l.messchendorp umcg.nl

Research

Publications
  1. Urine-to-plasma urea ratio, as surrogate marker for urine concentrating capacity, is associated with disease progression in adpkd

    Heida, J. E., Gansevoort, R., Messchendorp, L., Meijer, E., Casteleijn, N. F., Boertien, W. E. & Zittema, D., Jun-2020, In : Nephrology Dialysis Transplantation. 35, p. 97 1 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  2. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors

    DIPAK-1 Study Investigators, Nov-2019, In : American Journal of Nephrology. 50, 5, p. 375-385 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Effect of a Somatostatin Analogue on the Vasopressin Pathway in Patients With ADPKD

    DIPAK-1 Study Investigators, Messchendorp, A. L., Kramers, B. J., Spithoven, E. M., Stade, K., Meijer, E. & Gansevoort, R. T., Aug-2019, In : Kidney International Reports. 4, 8, p. 1170-1174 5 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Somatostatin in renal physiology and autosomal dominant polycystic kidney disease

    DIPAK Consortium Investigators, Messchendorp, A. L., Casteleijn, N. F., Meijer, E. & Gansevoort, R. T., 27-Apr-2019, In : Nephrology, Dialysis, Transplantation. 11 p., gfz054.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease

    DIPAK-1 Investigators, Aug-2019, In : Gastroenterology. 157, 2, p. 481-491.e7 18 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (22) »

ID: 13574731